Nishinomiya, Japan

Kumi Yamasaki

This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kumi Yamasaki. Retrieved from https://idiyas.com/inventor/kumi-yamasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kumi Yamasaki: Innovator in Medicinal Chemistry

Introduction

Kumi Yamasaki is a prominent inventor based in Nishinomiya, Japan. She has made significant contributions to the field of medicinal chemistry, particularly through her work on guanidine derivatives. With a total of 3 patents to her name, Yamasaki has established herself as a key figure in pharmaceutical innovation.

Latest Patents

Her latest patents include groundbreaking work on guanidine derivatives and benzoylguanidine derivatives as medicaments. These innovations have the potential to impact various therapeutic areas, showcasing her expertise and dedication to advancing medical science.

Career Highlights

Throughout her career, Kumi Yamasaki has worked with notable companies, including Fujisawa Pharmaceutical Company, Ltd. and Fujisawa Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to develop and refine her skills in drug development and medicinal chemistry.

Collaborations

Yamasaki has collaborated with esteemed colleagues such as Atsushi Kuno and Yoshikazu Inoue. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kumi Yamasaki's contributions to medicinal chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to inspire future advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…